A detailed history of First Trust Advisors LP transactions in Bio Techne Corp stock. As of the latest transaction made, First Trust Advisors LP holds 98,546 shares of TECH stock, worth $6.77 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
98,546
Previous 81,662 20.68%
Holding current value
$6.77 Million
Previous $5.85 Million 34.58%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$70.96 - $82.35 $1.2 Million - $1.39 Million
16,884 Added 20.68%
98,546 $7.87 Million
Q2 2024

Aug 13, 2024

BUY
$62.12 - $84.15 $666,299 - $902,592
10,726 Added 15.12%
81,662 $5.85 Million
Q1 2024

May 13, 2024

SELL
$65.98 - $77.09 $44.1 Million - $51.6 Million
-668,758 Reduced 90.41%
70,936 $4.99 Million
Q4 2023

Feb 13, 2024

BUY
$52.83 - $78.22 $8.4 Million - $12.4 Million
158,955 Added 27.37%
739,694 $57.1 Million
Q3 2023

Nov 13, 2023

SELL
$67.52 - $89.42 $689,176 - $912,709
-10,207 Reduced 1.73%
580,739 $39.5 Million
Q2 2023

Aug 14, 2023

SELL
$73.76 - $85.98 $9.31 Million - $10.9 Million
-126,279 Reduced 17.61%
590,946 $48.2 Million
Q1 2023

May 15, 2023

BUY
$71.62 - $86.62 $6.75 Million - $8.16 Million
94,238 Added 15.13%
717,225 $53.2 Million
Q4 2022

Feb 09, 2023

BUY
$80.67 - $352.29 $39.9 Million - $174 Million
494,032 Added 383.1%
622,987 $51.6 Million
Q3 2022

Nov 14, 2022

SELL
$282.54 - $391.85 $236,768 - $328,370
-838 Reduced 0.65%
128,955 $36.6 Million
Q2 2022

Aug 12, 2022

SELL
$322.67 - $449.65 $14.2 Million - $19.7 Million
-43,913 Reduced 25.28%
129,793 $45 Million
Q1 2022

May 13, 2022

SELL
$353.85 - $487.79 $6.3 Million - $8.69 Million
-17,806 Reduced 9.3%
173,706 $75.2 Million
Q4 2021

Feb 08, 2022

SELL
$456.15 - $525.06 $13.2 Million - $15.2 Million
-28,882 Reduced 13.1%
191,512 $99.1 Million
Q3 2021

Nov 15, 2021

SELL
$444.87 - $538.88 $7.41 Million - $8.97 Million
-16,653 Reduced 7.03%
220,394 $107 Million
Q2 2021

Aug 16, 2021

SELL
$387.35 - $450.26 $13.9 Million - $16.2 Million
-35,941 Reduced 13.17%
237,047 $107 Million
Q1 2021

May 14, 2021

BUY
$314.62 - $411.0 $2.16 Million - $2.82 Million
6,857 Added 2.58%
272,988 $104 Million
Q4 2020

Feb 02, 2021

SELL
$246.9 - $321.87 $18.6 Million - $24.2 Million
-75,253 Reduced 22.04%
266,131 $84.5 Million
Q3 2020

Nov 05, 2020

SELL
$232.22 - $282.96 $13.6 Million - $16.6 Million
-58,585 Reduced 14.65%
341,384 $84.6 Million
Q2 2020

Jul 22, 2020

BUY
$185.43 - $279.56 $7.3 Million - $11 Million
39,346 Added 10.91%
399,969 $106 Million
Q1 2020

May 06, 2020

BUY
$161.17 - $221.51 $13.6 Million - $18.8 Million
84,658 Added 30.68%
360,623 $68.4 Million
Q4 2019

Feb 03, 2020

SELL
$189.68 - $222.09 $23.7 Million - $27.7 Million
-124,914 Reduced 31.16%
275,965 $60.6 Million
Q3 2019

Nov 04, 2019

SELL
$183.56 - $216.72 $40.4 Million - $47.7 Million
-219,908 Reduced 35.42%
400,879 $78.4 Million
Q2 2019

Jul 30, 2019

SELL
$188.72 - $215.43 $9.59 Million - $10.9 Million
-50,808 Reduced 7.57%
620,787 $129 Million
Q1 2019

May 09, 2019

SELL
$136.09 - $200.44 $10.4 Million - $15.3 Million
-76,232 Reduced 10.19%
671,595 $133 Million
Q4 2018

Feb 07, 2019

BUY
$132.75 - $203.8 $9.94 Million - $15.3 Million
74,863 Added 11.12%
747,827 $108 Million
Q3 2018

Oct 25, 2018

BUY
$147.44 - $204.11 $28.9 Million - $40 Million
195,950 Added 41.08%
672,964 $137 Million
Q2 2018

Aug 02, 2018

BUY
$144.9 - $165.58 $8.94 Million - $10.2 Million
61,674 Added 14.85%
477,014 $70.6 Million
Q1 2018

Apr 23, 2018

BUY
$131.46 - $151.04 $571,719 - $656,872
4,349 Added 1.06%
415,340 $62.7 Million
Q4 2017

Feb 08, 2018

BUY
$121.17 - $134.75 $5.99 Million - $6.67 Million
49,470 Added 13.68%
410,991 $53.2 Million
Q3 2017

Oct 24, 2017

BUY
$113.59 - $123.78 $41.1 Million - $44.7 Million
361,521
361,521 $43.7 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.7B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.